Adipocytokines in Steatotic Liver Surgery/Transplantation
| Autor: | Elsa Negrete-Sánchez, Araní Casillas-Ramírez, Mónica B. Jiménez-Castro, Cindy G Avalos-de León, Carmen A. Peralta, Jordi Gracia-Sancho |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
Adipokine Severity of Illness Index Simple steatosis Basic knowledge Adipokines Fibrosis Severity of illness Animals Hepatectomy Humans Medicine Transplantation business.industry Allografts medicine.disease Liver Transplantation Surgery Fatty Liver Clinical Practice Disease Models Animal Treatment Outcome Liver Reperfusion Injury Tissue and Organ Harvesting Steatosis business Biomarkers Liver Failure |
| Zdroj: | Transplantation. 103:71-77 |
| ISSN: | 1534-6080 0041-1337 |
| DOI: | 10.1097/tp.0000000000002098 |
| Popis: | Because of the shortage of liver grafts available for transplantation, the restrictions on graft quality have been relaxed, and marginal grafts, such as steatotic livers, are now accepted. However, this policy change has not solved the problem, because steatotic liver grafts tolerate ischemia-reperfusion (I/R) injury poorly. Adipocytokines differentially modulate steatosis, inflammation, and fibrosis and are broadly present in hepatic resections and transplants. The potential use of adipocytokines as biomarkers of the severity of steatosis and liver damage to aid the identification of high-risk steatotic liver donors and to evaluate hepatic injury in the postoperative period are discussed. The hope of finding new therapeutic strategies aimed specifically at protecting steatotic livers undergoing surgery is a strong impetus for identifying the mechanisms responsible for hepatic failure after major surgical intervention. Hence, the most recently described roles of adipocytokines in steatotic livers subject to I/R injury are discussed, the conflicting results in the literature are summarized, and reasons are offered as to why strategic pharmacologic control of adipocytokines has yet to yield clinical benefits. After this, the next steps needed to transfer basic knowledge about adipocytokines into clinical practice to protect marginal livers subject to I/R injury are presented. Recent strategies based on adipocytokine regulation, which have shown efficacy in various pathologies, and hold promise for hepatic resection and transplantation are also outlined. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|